Arong, Vice Head of Right Banner in ASHAQI League, Visits SHOUYAO for Mutual Development

 On the morning of July 5th, Mr. Arong, Vice Head of Right Banner in ASHAQI League, led a delegation to visit SHOUYAO (Jiangsu) Biotechnology Co., Ltd. Chairman of SHOUYAO, Jun Yang, and CEO Zeying Qian, accompanied the delegation during the visit.

During the visit, Mr. Arong held an in-depth meeting with the senior management of SHOUYAO. Both sides engaged in a productive exchange and discussion regarding the development trends, technological innovations, and product research and development in the field of biotechnology. Mr. Arong acknowledged SHOUYAO's achievements in technology research and development, product quality, and market expansion.

Mr. Arong expressed his admiration for SHOUYAO (Jiangsu) Biotechnology Co., Ltd.'s impressive accomplishments in the small molecule peptides field, emphasizing their positive contribution to the biotechnology industry's development. He also committed to further enhancing the People's Government of Right Banner in ASHAQI League's support for the biotechnology industry, providing an improved environment and policy support for business innovation and development.

During the visit, both parties reached a consensus to strengthen their cooperation. In the future, the People's Government of Right Banner in ASHAQI League will engage in comprehensive strategic cooperation with SHOUYAO, jointly seeking opportunities for the development of biotechnology. This collaboration will offer more opportunities for partnership and resource sharing between the two companies and drive innovation and application in the biotechnology sector, ultimately making a significant contribution to human health and well-being.

SHOUYAO Group is dedicated to the innovation, research, development, production, marketing, health management, and investment In small-molecule peptide solutions. Leveraging biologically active peptide technology, the company conducts in-depth development of traditional medicinal and edible raw materials to produce more efficient and safer biologically active peptide products. over 80 types of small-molecule peptide solutions derived from medicinal and edible sources. After completing its first-phase construction, the company is going to be in full-scale production. SHOUYAO (Datong) Biotechnology Co., Ltd is capable of producing 2,700 tons of small molecule peptide liquid beverages per year, while Aishi Medical Device Technology (Shanxi) Co., Ltd. is capable of manufacturing 160 tons of small molecule peptide medical devices annually. . SHOUYAO Group offers product research and development, technical services, and sales to a wide range of food, functional food, and biopharmaceutical enterprises and customers, promoting the scientific development of the traditional Chinese medicine industry. Additionally, the company is in the process of establishing a digital health management system.